An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays.
Laufer
Stefan
S
Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard-Karls-University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany. stefan.laufer@uni-tuebingen.de
Thuma
Sabine
S
Peifer
Christian
C
Greim
Cornelia
C
Herweh
Yvonne
Y
Albrecht
Angela
A
Dehner
Frank
F
D051698:Activating Transcription Factor 2 / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000032:analysis*; D007093:Imidazoles / Q000494:pharmacology; D007163:Immunosorbent Techniques; D020128:Inhibitory Concentration 50; D011725:Pyridines / Q000494:pharmacology; D019311:Staurosporine / Q000494:pharmacology; D048051:p38 Mitogen-Activated Protein Kinases / Q000032:analysis* / Q000037:antagonists & inhibitors
D051698:Activating Transcription Factor 2; C497106:Atf2 protein, mouse; D004791:Enzyme Inhibitors; D007093:Imidazoles; D011725:Pyridines; D048051:p38 Mitogen-Activated Protein Kinases; D019311:Staurosporine; C093642:SB 203580; C090942:4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole